Discover how clinical and regulatory strategies shape medtech success from investment decisions to commercialization
- Published
- Genre
- News & Current Affairs
External source
lsiusasummit.com External website
You are viewing the Vahuk Story page. The link above opens the shared source website.
Success in medtech innovation requires more than groundbreaking technology. During a panel at LSI USA ‘24, Ivanny Franklin of NAMSA emphasized the pivotal role of clinical and regulatory strategies in shaping investment decisions and driving long-term outcomes. Joined by distinguished panelists—Auriel August of Santé Ventures, Edwin Lindsay of Compliance Solutions Life Sciences, Nir Goldenberg of Mayo Clinic Ventures, and Adam Saltman of NAMSA—Franklin explored how regulatory rigor and clinical diligence intersect with investment value.
Community reactions
Karma 20.3
Discussion
0 comments
No comments yet. Be the first to join the discussion.